Am J Perinatol 2023; 40(16): 1827-1833
DOI: 10.1055/s-0041-1739435
Original Article

Idiopathic Polyhydramnios and Neonatal Morbidity at Term

Brock Polnaszek
1   Division of Maternal Fetal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
,
Brooke Liang
1   Division of Maternal Fetal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
,
Fan Zhang
1   Division of Maternal Fetal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
,
Alison G. Cahill
2   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The University of Texas at Austin Dell Medical School, Austin, Texas
,
Nandini Raghuraman
1   Division of Maternal Fetal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
,
Omar M. Young
3   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina
› Author Affiliations
Funding None.

Abstract

Objective Idiopathic polyhydramnios is among the most common etiologies of polyhydramnios. However, conflicting evidence exists regarding the relationship between polyhydramnios and neonatal morbidity. We investigated the association between pregnancies with and without idiopathic polyhydramnios and neonatal morbidity at term.

Study Design This is a retrospective cohort study of singleton, term (i.e., ≥370/7 weeks) pregnancies from 2014 to 2018. Pregnancies complicated by fetal anomalies, pregestational diabetes, and multifetal gestation were excluded. Pregnancies complicated by idiopathic polyhydramnios were defined by the deepest vertical pocket (DVP) ≥8 cm or amniotic fluid index (AFI) ≥24 cm after 20 weeks' gestation and were compared with women without polyhydramnios at time of delivery. These groups were matched 1:2 by gestational age within 7 days at delivery and maternal race. The primary outcome was a composite neonatal morbidity (neonatal death, respiratory morbidity, hypoxic–ischemic encephalopathy, therapeutic hypothermia, seizures, and umbilical artery pH < 7.10). Outcomes were compared between pregnancies with and without idiopathic polyhydramnios. Unadjusted and adjusted risk ratios were estimated using multivariable logistic regression.

Results Idiopathic polyhydramnios was diagnosed in 192 pregnancies and were matched to 384 pregnancies without polyhydramnios. After adjustment for obesity, women with pregnancies complicated by idiopathic polyhydramnios had an increased risk of composite neonatal morbidity 21.4 versus 5.5% (adjusted risk ratio [aRR] = 4.0, 95% confidence interval [CI]: 2.3–6.7). Term neonatal respiratory morbidity was the primary driver 20.3 versus 4.2%, (aRR = 4.8, 95% CI: 2.7–8.7) and included higher use of continuous positive airway pressure 19.8 versus 3.4%, p <0.01 and the need for supplemental oxygen at >12 hours of newborn life 6.8 versus 1.8%, p <0.01.

Conclusion Idiopathic polyhydramnios is associated with term neonatal respiratory morbidity at delivery and during the subsequent hours of newborn life, compared with pregnancies without idiopathic polyhydramnios. Further studies are needed to minimize neonatal morbidity at term.

Key Points

  • Idiopathic polyhydramnios is associated with increased risk of neonatal morbidity at term.

  • Increasing idiopathic polyhydramnios severity was associated with a trend toward worsening morbidity at term.

  • Idiopathic polyhydramnios at term requires respiratory support at delivery and during neonatal care.

Note

This study was partly presented as a poster at Society for Maternal Fetal Medicine Annual Research Meeting, January 28, 2021.




Publication History

Received: 27 January 2021

Accepted: 03 October 2021

Article published online:
14 November 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Dashe JS, Pressman EK, Hibbard JU. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. SMFM consult series #46: evaluation and management of polyhydramnios. Am J Obstet Gynecol 2018; 219 (04) B2-B8
  • 2 Hershey DW. Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. J Ultrasound Med 2014; 33 (10) 1876
  • 3 Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. II. The relationship of increased amniotic fluid volume to perinatal outcome. Am J Obstet Gynecol 1984; 150 (03) 250-254
  • 4 Biggio Jr JR, Wenstrom KD, Dubard MB, Cliver SP. Hydramnios prediction of adverse perinatal outcome. Obstet Gynecol 1999; 94 (5, pt. 1): 773-777
  • 5 Khan S, Donnelly J. Outcome of pregnancy in women diagnosed with idiopathic polyhydramnios. Aust N Z J Obstet Gynaecol 2017; 57 (01) 57-62
  • 6 Pri-Paz S, Khalek N, Fuchs KM, Simpson LL. Maximal amniotic fluid index as a prognostic factor in pregnancies complicated by polyhydramnios. Ultrasound Obstet Gynecol 2012; 39 (06) 648-653
  • 7 Odibo IN, Newville TM, Ounpraseuth ST. et al. Idiopathic polyhydramnios: persistence across gestation and impact on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2016; 199: 175-178
  • 8 Abele H, Starz S, Hoopmann M, Yazdi B, Rall K, Kagan KO. Idiopathic polyhydramnios and postnatal abnormalities. Fetal Diagn Ther 2012; 32 (04) 251-255
  • 9 Dickinson JE, Tjioe YY, Jude E, Kirk D, Franke M, Nathan E. Amnioreduction in the management of polyhydramnios complicating singleton pregnancies. Am J Obstet Gynecol 2014; 211 (04) 434.e1-434.e7
  • 10 Chen KC, Liou JD, Hung TH. et al. Perinatal outcomes of polyhydramnios without associated congenital fetal anomalies after the gestational age of 20 weeks. Chang Gung Med J 2005; 28 (04) 222-228
  • 11 Phelan JP, Park YW, Ahn MO, Rutherford SE. Polyhydramnios and perinatal outcome. J Perinatol 1990; 10 (04) 347-350
  • 12 Wiegand SL, Beamon CJ, Chescheir NC, Stamilio D. Idiopathic polyhydramnios: severity and perinatal morbidity. Am J Perinatol 2016; 33 (07) 658-664
  • 13 Panting-Kemp A, Nguyen T, Chang E, Quillen E, Castro L. Idiopathic polyhydramnios and perinatal outcome. Am J Obstet Gynecol 1999; 181 (5, pt. 1): 1079-1082
  • 14 Luo QQ, Zou L, Gao H, Zheng YF, Zhao Y, Zhang WY. Idiopathic polyhydramnios at term and pregnancy outcomes: a multicenter observational study. J Matern Fetal Neonatal Med 2017; 30 (14) 1755-1759
  • 15 Pilliod RA, Page JM, Burwick RM, Kaimal AJ, Cheng YW, Caughey AB. The risk of fetal death in nonanomalous pregnancies affected by polyhydramnios. Am J Obstet Gynecol 2015; 213 (03) 410.e1-410.e6
  • 16 Moessinger AC, Harding R, Adamson TM, Singh M, Kiu GT. Role of lung fluid volume in growth and maturation of the fetal sheep lung. J Clin Invest 1990; 86 (04) 1270-1277
  • 17 Karahanoglu E, Ozdemirci S, Esinler D. et al. Intrapartum, postpartum characteristics and early neonatal outcomes of idiopathic polyhydramnios. J Obstet Gynaecol 2016; 36 (06) 710-714
  • 18 Bajaj M, Natarajan G, Shankaran S. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Delivery room resuscitation and short-term outcomes in moderately preterm infants. J Pediatr 2018; 195: 33-38.e2
  • 19 Afjeh SA, Sabzehei MK, Esmaili F. Neonatal resuscitation in the delivery room from a tertiary level hospital: risk factors and outcome. Iran J Pediatr 2013; 23 (06) 675-680
  • 20 Matsumoto LC, Bogic L, Brace RA, Cheung CY. Fetal esophageal ligation induces expression of vascular endothelial growth factor messenger ribonucleic acid in fetal membranes. Am J Obstet Gynecol 2001; 184 (02) 175-184
  • 21 Bates DO, Hillman NJ, Williams B, Neal CR, Pocock TM. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 2002; 200 (06) 581-597
  • 22 Liu H, Zheng Z, Wintour EM. Aquaporins and fetal fluid balance. Placenta 2008; 29 (10) 840-847
  • 23 Mann SE, Dvorak N, Gilbert H, Taylor RN. Steady-state levels of aquaporin 1 mRNA expression are increased in idiopathic polyhydramnios. Am J Obstet Gynecol 2006; 194 (03) 884-887
  • 24 Zhu X, Jiang S, Hu Y. et al. The expression of aquaporin 8 and aquaporin 9 in fetal membranes and placenta in term pregnancies complicated by idiopathic polyhydramnios. Early Hum Dev 2010; 86 (10) 657-663
  • 25 Huang J, Qi HB. [Expression of aquaporin 8 in human fetal membrane and placenta of idiopathic polyhydramnios]. Zhonghua Fu Chan Ke Za Zhi 2009; 44 (01) 19-22
  • 26 Leguizamón G, Smith J, Younis H, Nelson DM, Sadovsky Y. Enhancement of amniotic cyclooxygenase type 2 activity in women with preterm delivery associated with twins or polyhydramnios. Am J Obstet Gynecol 2001; 184 (02) 117-122
  • 27 Clyman RI, Brett C, Mauray F. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatrics 1980; 66 (05) 725-729
  • 28 Philips III JB, Lyrene RK. Prostaglandins, related compounds, and the perinatal pulmonary circulation. Clin Perinatol 1984; 11 (03) 565-579
  • 29 Liu L, Tuuli MG, Roehl KA, Odibo AO, Macones GA, Cahill AG. Electronic fetal monitoring patterns associated with respiratory morbidity in term neonates. Am J Obstet Gynecol 2015; 213 (05) 681.e1-681.e6
  • 30 Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Risk of respiratory morbidity in term infants delivered by elective caesarean section: cohort study. BMJ 2008; 336 (7635): 85-87
  • 31 Edwards MO, Kotecha SJ, Kotecha S. Respiratory distress of the term newborn infant. Paediatr Respir Rev 2013; 14 (01) 29-36 , quiz 36–37
  • 32 Tita AT, Landon MB, Spong CY. et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med 2009; 360 (02) 111-120